A crucial element of regenerative medicine and drug investigation lies in the ability to multiply human stem cell groups to sufficient numbers for therapeutic uses. Traditionally, limited cell availability posed a significant hindrance to development in these fields. Consequently, considerable work has been directed towards optimizing procedures fo